HSD17B13 and metabolic dysfunction-associated steatotic liver disease: To further validate the relationship between the HSD17B13 expression and NAFLD progression, we detected HSD17B13 expression in liver samples from patients with NAFLD using immunohistochemical analysis (Supplementary Table S1).